BGB-B3227
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGB-B3227, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors [Phase 1]